# Empyema — GCMD Library living collection

Everything in the library about empyema — built automatically from dossiers that name it.

Updated: n/a · 3 episodes · 72 cited statements

## Episodes
### Medical Management
- [Empyema with Dr. Shawn St. Peter](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312) — podcast · 36:37 · [machine version](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312.md)

### Evidence & Research
- [Empyema and Pneumothorax: Update Course 2014](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646) — video · 31:32 · [machine version](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646.md)

### In-Depth Reviews
- [Empyema with Dr. Shawn St. Peter](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932) — podcast · 36:37 · [machine version](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932.md)

## Chapters
- [0:00](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=0) Introduction and Dr. St. Peter's Background (Ep 3)
- [1:45](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=105) Initial Assessment and Diagnostic Approach (Ep 3)
- [7:39](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=459) Randomized Trial Results: VATS versus Fibrinolysis (Ep 3)
- [16:59](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1019) TPA Protocol and Supporting Evidence (Ep 3)
- [20:26](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1226) Practical Implementation and Monitoring (Ep 3)
- [23:46](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1426) Defining and Managing Fibrinolysis Failure (Ep 3)
- [29:11](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1751) Pulmonary Necrosis and Contraindications to Surgery (Ep 3)
- [34:27](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=2067) Pulmonary Abscess Management and Alternative Agents (Ep 3)
- [0:00](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=0) Empyema case presentation and initial management debate (Ep 1)
- [5:32](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=332) Evidence review: fibrinolytic therapy versus VATS (Ep 1)
- [10:49](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=649) Clinical decision-making: timing and patient selection (Ep 1)
- [15:06](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=906) Ultrasound limitations and intraparenchymal disease (Ep 1)
- [16:47](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1007) Spontaneous pneumothorax: small pneumothorax management (Ep 1)
- [20:50](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1250) Large pneumothorax and role of CT imaging (Ep 1)
- [24:14](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1454) VATS technique and pleurodesis strategies (Ep 1)
- [0:00](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=0) Introduction and Initial Assessment of Parapneumonic Effusions (Ep 2)
- [3:12](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=192) Diagnostic Criteria and Ultrasound Evaluation (Ep 2)
- [7:39](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=459) Randomized Trial Results: VATS versus Fibrinolysis (Ep 2)
- [15:08](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=908) Fibrinolysis Protocol and Technical Details (Ep 2)
- [20:26](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1226) Operating Room Considerations and Sedation Approaches (Ep 2)
- [23:46](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1426) Post-Treatment Monitoring and Failure Criteria (Ep 2)
- [27:57](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1677) Management of Pulmonary Necrosis (Ep 2)
- [31:01](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1861) ECMO Support and Pulmonary Abscess Management (Ep 2)
- [34:27](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=2067) Alternative Fibrinolytic Agents and Antibiotic Duration (Ep 2)

## Statements
Every statement is attributed, typed, and timestamped; the link is the citation.
- "Ultrasound has no disadvantage compared to CT for diagnosing empyema and identifying pleural stranding, and prospective studies show that placing ultrasound before CT decreases CT utilization without changing outcomes." — Shawn St. Peter (clinical) [Ep 3 · 15:16](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=916)
- "Empyema is defined by pleural fluid with greater than 10,000 white blood cells, which was the enrollment criterion used in the randomized trial." — Shawn St. Peter (clinical) [Ep 3 · 6:50](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=410)
- "When pleural fluid has >10,000 white cells and the patient undergoes VATS, the pleural space appearance is consistent with typical empyema." — Shawn St. Peter (clinical) [Ep 3 · 7:02](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=422)
- "The randomized trial at Children's Mercy compared primary VATS to primary fibrinolysis and found no difference in length of stay, with a 16% failure rate in the fibrinolysis group." — Shawn St. Peter (clinical) [Ep 3 · 7:39](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=459)
- "Great Ormond Street published a study of 60 patients using urokinase with 4-hour dwell time that found identical results: no difference in length of stay and a 1 in 6 (approximately 16%) failure rate." — Shawn St. Peter (clinical) [Ep 3 · 17:34](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1054)
- "A Spanish randomized trial of 100 patients using urokinase found no difference in length of stay and a 15% failure rate, consistent with prior studies." — Shawn St. Peter (clinical) [Ep 3 · 19:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1154)
- "Three randomized trials totaling 200 patients all show the same results: no difference in length of stay between VATS and fibrinolysis, with 15-16% failure rate for fibrinolysis." — Shawn St. Peter (clinical) [Ep 3 · 19:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1154)
- "In 100 consecutive patients treated with fibrinolysis after the trial, there was no difference in operative time or blood loss for patients who required subsequent VATS compared to primary VATS, contradicting concerns that fibrinolysis makes subsequent surgery more difficult." — Shawn St. Peter (clinical) [Ep 3 · 19:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1154)
- "The TPA protocol is 4mg mixed in 40mL normal saline, instilled into a 12 French chest tube with 1-hour dwell time, repeated at 24 and 48 hours (three doses total over 48 hours)." — Shawn St. Peter (clinical) [Ep 3 · 16:03](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=963)
- "Patients do not get sicker with fibrinolysis, unlike VATS where barrel trauma to the good lung and manipulation of the bad lung can cause patients to 'fly pretty close to the treetop' postoperatively." — Shawn St. Peter (opinion) [Ep 3 · 9:40](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=580)
- "Daily chest X-rays after fibrinolysis are not useful because the chest will look bad for quite a while even after completing treatment, and X-ray appearance does not help determine if fibrinolysis has failed." — Shawn St. Peter (clinical) [Ep 3 · 23:25](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1405)
- "Failure of fibrinolysis should be defined by persistent clinical illness (oxygen requirement, poor feeding) at 3-4 days after treatment, not by fever alone, since fever may be due to parenchymal disease." — Shawn St. Peter (clinical) [Ep 3 · 23:57](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1437)
- "A second round of fibrinolysis is only indicated when imaging shows a walled-off collection not in continuity with the initial chest tube placement; if the tube is well-positioned and there is persistent pleural disease in continuity with the tube, a second round is not recommended." — Shawn St. Peter (clinical) [Ep 3 · 26:42](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1602)
- "Extensive pulmonary necrosis is an absolute contraindication to surgical intervention because manipulating necrotic lung risks protracted bronchopleural fistulas requiring Heimlich valves for months." — Shawn St. Peter (clinical) [Ep 3 · 26:53](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1613)
- "Bronchopleural fistulas only occur when operating in a field of necrosis and debriding that necrosis; peripheral lung lesions heal without this complication." — Shawn St. Peter (clinical) [Ep 3 · 26:53](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1613)
- "During VATS for failed fibrinolysis, if the lung appears necrotic (black, necrotic-appearing), it should be left alone and only the pleural space should be debrided." — Shawn St. Peter (clinical) [Ep 3 · 29:11](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1751)
- "A patient with complete unilateral pulmonary necrosis who underwent needle biopsy died from exsanguination into the wound and bronchi, demonstrating that necrotic lung does not tolerate being touched." — Shawn St. Peter (clinical) [Ep 3 · 29:50](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1790)
- "A 3-year-old with bilateral pulmonary necrosis requiring VV ECMO for almost a month survived without surgical intervention and left the hospital without oxygen, demonstrating that necrotic lung heals with conservative management." — Shawn St. Peter (clinical) [Ep 3 · 31:21](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1881)
- "Well-defined peripheral pulmonary abscesses can be drained percutaneously with a drain left in place, but multifocal or complex abscesses should be managed conservatively like necrosis." — Shawn St. Peter (clinical) [Ep 3 · 32:06](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1926)
- "The IDSA community-acquired pneumonia guidelines recommend 10 days of antibiotics after becoming afebrile, but this is a grade D recommendation based on no data." — Shawn St. Peter (host_summary) [Ep 3 · 11:20](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=680)
- "At Children's Mercy, the average duration of antibiotics was 25 days total with 19 days after becoming afebrile, and 40% of patients had complications from antibiotic therapy including diarrhea and fungal superinfections." — Shawn St. Peter (clinical) [Ep 3 · 11:41](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=701)
- "The current antibiotic protocol at Children's Mercy is 7 days after meeting three criteria: completed fibrinolysis, off oxygen, and afebrile. Antibiotics can be switched to oral if the patient is a candidate." — Shawn St. Peter (clinical) [Ep 3 · 13:00](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=780)
- "Recurrent empyema after successful treatment is extremely rare because the pleural space is typically obliterated (cemented space), making randomized trials of antibiotic duration unfeasible due to zero event rate." — Shawn St. Peter (clinical) [Ep 3 · 13:00](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=780)
- "In the United States, TPA is the only available fibrinolytic agent for empyema since urokinase is not available and streptokinase has come off the market." — Shawn St. Peter (clinical) [Ep 3 · 34:27](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=2067)
- "A randomized trial in adults suggested more rapid clearance by adding DNase to fibrinolytic therapy, but DNase is not approved for intrapleural use and requires an IND for pediatric study." — Shawn St. Peter (clinical) [Ep 3 · 34:37](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=2077)
- "Mary Anne Jackson, an infectious disease physician, recommended the >10,000 white cell entry criterion for the trial, which initially seemed too soft but proved completely correct." — Shawn St. Peter (clinical) [Ep 3 · 4:40](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=280)
- "When comparing an operation to a non-operative approach, if results are equal, there is no way to recommend the operation and no parent would choose surgery when outcomes are the same." — Shawn St. Peter (opinion) [Ep 3 · 18:20](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1100)
- "Placing a 12 French chest tube under ultrasound guidance is less invasive and faster than placing a PICC line, taking less than a minute." — Shawn St. Peter (clinical) [Ep 3 · 21:06](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1266)
- "In older children who are not severely tachypneic, chest tube placement can be performed with local anesthetic alone without sedation." — Shawn St. Peter (clinical) [Ep 3 · 22:20](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=1340)
- "Ted Carter and colleagues from Seattle proposed an algorithm for pleural effusions categorizing them as small (<25%), moderate (25-50%), or large (>50%), with symptomatic versus asymptomatic branches under each category." — Shawn St. Peter (host_summary) [Ep 3 · 5:10](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-312?t=310)
- "Stage 2 empyema is defined by loculated pleural effusion with greater than 100,000 white cells" — Dan Ostlie (clinical) [Ep 1 · 3:51](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=231)
- "Once stage 2 empyema is present, antibiotics alone are insufficient and intervention is needed to remove fibrinous exudate" — Dan Ostlie (clinical) [Ep 1 · 3:51](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=231)
- "A meta-analysis of 170 patients showed primary VATS (M3 arm) had better outcomes than chest tube with fibrinolytic followed by delayed thoracoscopy/thoracotomy, but the VATS cases were concentrated in later years creating temporal bias" — Dan Ostlie (host_summary) [Ep 1 · 5:32](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=332)
- "A trial of 60 patients comparing urokinase versus saline with small versus large drains showed small tube with urokinase performed better than other combinations, with no operations required" — Dan Ostlie (host_summary) [Ep 1 · 7:09](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=429)
- "The London (Great Ormond Street) trial using urokinase showed length of stay 6 days, cost 13 (units unclear), 9% complication rate, and 16% failure rate" — Dan Ostlie (host_summary) [Ep 1 · 7:09](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=429)
- "The Kansas City trial using TPA showed length of stay 6.8 days, cost $11.6K, 7.5% complication rate, and 15% failure rate" — Dan Ostlie (clinical) [Ep 1 · 7:09](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=429)
- "Both fibrinolytic trials demonstrate 85% success rate, meaning 15% of patients require subsequent surgical intervention" — Dan Ostlie (clinical) [Ep 1 · 8:14](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=494)
- "In the Kansas City VATS cohort, 2 children required oscillator support and 1 developed renal failure requiring hemodialysis; no such complications occurred in the TPA arm" — Dan Ostlie (clinical) [Ep 1 · 11:30](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=690)
- "Post-operative illness after empyema VATS is primarily due to underlying pneumonia rather than residual pleural disease" — Arnie (clinical) [Ep 1 · 9:09](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=549)
- "Length of stay is identical between TPA and VATS groups even though TPA numbers include intention-to-treat analysis with all failures who required subsequent VATS" — Todd Ponsky (host_summary) [Ep 1 · 10:10](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=610)
- "Percutaneous Seldinger-type chest tubes can be placed at bedside under local anesthesia with minimal sedation in approximately 2 minutes" (clinical) [Ep 1 · 13:40](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=820)
- "Ultrasound can sometimes fail to distinguish intraparenchymal necrotic lung from pleural effusion, requiring CT for accurate diagnosis" — Dan Ostlie (clinical) [Ep 1 · 15:47](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=947)
- "Intraparenchymal lung necrosis requires antibiotic therapy only and does not need surgical intervention" — Arnie (clinical) [Ep 1 · 16:04](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=964)
- "A 5–10% apical pneumothorax in a minimally symptomatic patient should be observed with oxygen supplementation" — Todd Ponsky (host_summary) [Ep 1 · 17:08](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1028)
- "Oxygen supplementation for small pneumothorax is standard practice though its efficacy is uncertain" (opinion) [Ep 1 · 17:26](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1046)
- "Simple aspiration of pneumothorax may seal a tiny hole or relieve symptoms, but risks creating a larger pneumothorax if a needle is used" (clinical) [Ep 1 · 18:17](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1097)
- "2001 Adelphi consensus guidelines stated there was no role for simple aspiration in pneumothorax management" — Dan Ostlie (host_summary) [Ep 1 · 19:50](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1190)
- "2010 British Thoracic Society guidelines recommend simple aspiration as first-line therapy for pneumothorax" — Dan Ostlie (host_summary) [Ep 1 · 19:50](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1190)
- "A Cochrane review (2007) with one RCT comparing manual aspiration versus chest tube in patients aged 16 and older showed 59% immediate success rate with aspiration, 50% avoided hospitalization, and no difference in overall hospital stay or recurrence rate" — Dan Ostlie (host_summary) [Ep 1 · 19:50](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1190)
- "Spontaneous pneumothorax is rare in children under 16 years old and predominantly occurs in teenagers approaching adulthood" — Todd Ponsky (epidemiological) [Ep 1 · 20:50](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1250)
- "Nearly all teenage patients with spontaneous pneumothorax have apical blebs visible on imaging" — Arnie (clinical) [Ep 1 · 21:17](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1277)
- "Patients with spontaneous pneumothorax typically have asthenic body habitus with thin chest capacity" — Todd Ponsky (clinical) [Ep 1 · 21:57](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1317)
- "CT imaging for pneumothorax allows visualization of blebs and assessment of the contralateral lung" (clinical) [Ep 1 · 22:36](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1356)
- "In adult thoracic surgery practice, the standard approach is to treat the symptomatic side with blebs and monitor the contralateral side, intervening only if a second pneumothorax develops" — Arnie (host_summary) [Ep 1 · 23:38](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1418)
- "Before the era of VATS, the standard was to wait for a second pneumothorax before performing anterior thoracotomy for bleb resection and pleural abrasion" — Dan Ostlie (clinical) [Ep 1 · 24:25](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1465)
- "Current practice is more aggressive, with many surgeons performing VATS on first pneumothorax rather than waiting for recurrence" — Todd Ponsky (clinical) [Ep 1 · 24:44](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1484)
- "Standard VATS technique for pneumothorax includes apical wedge resection and mechanical pleurodesis by roughing the pleura with a scratch pad" — Todd Ponsky (clinical) [Ep 1 · 26:12](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1572)
- "Talc pleurodesis distributes uniformly throughout the chest during thoracoscopy but creates dense adhesions that make future thoracic surgery extremely difficult, sometimes requiring retropleural approach" — Todd Ponsky (clinical) [Ep 1 · 27:02](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1622)
- "Mechanical pleurodesis is considered adequate when small blood vessels become prominent on the pleural surface" — Dan Ostlie (clinical) [Ep 1 · 28:15](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1695)
- "Some surgeons perform mechanical pleurodesis on both visceral and parietal pleura, though this may increase air leak risk" — Todd Ponsky (clinical) [Ep 1 · 27:02](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1622)
- "A study of 350 patients undergoing lung procedures (not specifically pneumothorax) showed no complications when chest tubes were omitted post-operatively" — Todd Ponsky (clinical) [Ep 1 · 29:20](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1760)
- "Reliable post-operative nursing surveillance is essential when omitting chest tubes after pneumothorax surgery to detect early re-accumulation" — Todd Ponsky (clinical) [Ep 1 · 29:20](https://library.globalcastmd.com/watch/empyema-and-pneumothorax-update-course-2014-646?t=1760)
- "Effusions greater than one-third of the chest with severe respiratory symptoms typically warrant aspiration, though this threshold is arbitrary and clinical judgment is required." — Shawn St. Peter (clinical) [Ep 2 · 3:12](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=192)
- "Pleural fluid with greater than 10,000 white blood cells defines empyema and was used as enrollment criteria for the randomized trial." — Shawn St. Peter (clinical) [Ep 2 · 5:01](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=301)
- "Ultrasound has no disadvantage compared to CT for diagnosing pleural disease and identifying septations in empyema." — Shawn St. Peter (host_summary) [Ep 2 · 15:08](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=908)
- "The randomized trial comparing primary VATS to primary fibrinolysis showed no difference in length of stay between the two approaches." — Shawn St. Peter (clinical) [Ep 2 · 7:39](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=459)
- "Both the Kansas City trial and Great Ormond Street study found a 1 in 6 (approximately 16%) failure rate for fibrinolysis." — Shawn St. Peter (clinical) [Ep 2 · 17:34](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1054)
- "A Spanish randomized trial of 100 patients using urokinase found no difference in length of stay and a 15% failure rate, confirming earlier findings." — Shawn St. Peter (host_summary) [Ep 2 · 19:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1154)
- "In 100 consecutive patients treated with fibrinolysis after the trial, results remained consistent with a 15% failure rate and similar length of stay." — Shawn St. Peter (clinical) [Ep 2 · 19:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1154)
- "There was no difference in operative time or blood loss for VATS performed after failed fibrinolysis compared to primary VATS." — Shawn St. Peter (clinical) [Ep 2 · 19:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1154)
- "The fibrinolysis protocol uses 4mg TPA mixed in 40mL normal saline with 1-hour dwell time, administered at 0, 24, and 48 hours (3 doses over 48 hours)." — Shawn St. Peter (clinical) [Ep 2 · 16:03](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=963)
- "Patients receiving fibrinolysis do not get sicker during treatment, unlike some patients after VATS who can be critically ill due to trauma to both lungs." — Shawn St. Peter (clinical) [Ep 2 · 11:09](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=669)
- "Chest X-rays are not useful for daily monitoring or determining fibrinolysis failure, as the radiographic appearance remains poor even after successful treatment." — Shawn St. Peter (clinical) [Ep 2 · 23:14](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1394)
- "Failure of fibrinolysis is defined clinically by persistent illness (oxygen requirement, poor feeding) at 3-4 days, not by fever alone." — Shawn St. Peter (clinical) [Ep 2 · 23:58](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1438)
- "A second round of fibrinolysis is indicated only when the chest tube is walled off and a separate collection exists that was not in continuity with the initial tube placement." — Shawn St. Peter (clinical) [Ep 2 · 26:42](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1602)
- "Extensive pulmonary necrosis is an absolute contraindication to surgical intervention, as manipulation of necrotic lung risks severe complications including bronchopleural fistula." — Shawn St. Peter (clinical) [Ep 2 · 26:53](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1613)
- "A patient with complete pulmonary necrosis died after needle biopsy, exsanguinating into the wound and bronchi, demonstrating that necrotic lung does not tolerate being touched." — Shawn St. Peter (clinical) [Ep 2 · 29:50](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1790)
- "A 3-year-old with bilateral pulmonary necrosis survived after nearly one month on VV ECMO with non-operative management and came off ECMO without oxygen requirement." — Shawn St. Peter (clinical) [Ep 2 · 31:21](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1881)
- "During VATS for empyema, necrotic lung should be left alone rather than debrided, following the principle of cleaning the pleural space while avoiding lung manipulation." — Shawn St. Peter (clinical) [Ep 2 · 29:11](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1751)
- "Well-defined peripheral pulmonary abscesses can be drained percutaneously, but multifocal or complex abscesses should be managed conservatively like necrosis." — Shawn St. Peter (clinical) [Ep 2 · 32:06](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1926)
- "The IDSA community-acquired pneumonia guidelines recommend 10 days of antibiotics after being afebrile, but this is a grade D recommendation based on no data." — Shawn St. Peter (host_summary) [Ep 2 · 11:09](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=669)
- "Historical practice at Children's Mercy showed an average of 25 days total antibiotics with 19 days after becoming afebrile, with 40% of patients experiencing antibiotic-related complications." — Shawn St. Peter (epidemiological) [Ep 2 · 11:09](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=669)
- "The current antibiotic protocol is 7 days after meeting three criteria: completing fibrinolysis, being afebrile, and being off oxygen." — Shawn St. Peter (clinical) [Ep 2 · 11:09](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=669)
- "Recurrent empyema after successful treatment is extremely rare because the pleural space typically becomes obliterated." — Shawn St. Peter (clinical) [Ep 2 · 11:09](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=669)
- "Placing a chest tube in the operating room with sedation but without intubation and positive pressure ventilation preserves some advantages of the non-operative approach." — Shawn St. Peter (clinical) [Ep 2 · 20:26](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=1226)
- "In the United States, TPA is the only available fibrinolytic agent for empyema since urokinase is not available and streptokinase has come off the market." — Shawn St. Peter (clinical) [Ep 2 · 34:27](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=2067)
- "An adult randomized trial suggested adding DNase to TPA may provide more rapid clearance, but DNase requires an investigational new drug (IND) application for intrapleural use." — Shawn St. Peter (host_summary) [Ep 2 · 34:27](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=2067)
- "Mary Anne Jackson, an infectious disease specialist, recommended the 10,000 white cell threshold as an entry criterion for the trial, which proved accurate." — Shawn St. Peter (host_summary) [Ep 2 · 5:01](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=301)
- "Ted Carter and colleagues in Seattle proposed an algorithm categorizing effusions as small (<25%), moderate (25-50%), or large (>50%), with symptomatic versus asymptomatic branches." — Shawn St. Peter (host_summary) [Ep 2 · 5:10](https://library.globalcastmd.com/watch/empyema-with-dr-shawn-st-peter-932?t=310)

## Changelog
- Sep 16: 3 items added automatically

---
Educational content from recorded physician discussions — not medical advice. Cite the canonical URL or the ?t= deep link. Policy: https://library.globalcastmd.com/ai